These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 2709678)
81. A primed-infusion technique for rapid estimation of the metabolic clearance rate of 1,25(OH)2D3. Eastell R; Riggs BL; Kumar R Am J Physiol; 1987 Sep; 253(3 Pt 1):E246-50. PubMed ID: 3631255 [TBL] [Abstract][Full Text] [Related]
82. Dietary phosphorus and 1,25-dihydroxyvitamin D metabolism: influence of insulin-like growth factor I. Halloran BP; Spencer EM Endocrinology; 1988 Sep; 123(3):1225-9. PubMed ID: 3402383 [TBL] [Abstract][Full Text] [Related]
83. Graded nephron mass reduction and renal synthesis of 1,25-dihydroxyvitamin D3 in the rat. Kawaguchi Y; Kimura Y; Yamamoto M; Imamura N; Tukui I; Horiuchi N; Suda T; Ogura Y; Oda Y; Miyahara T Metab Bone Dis Relat Res; 1983; 4(6):333-6. PubMed ID: 6689357 [TBL] [Abstract][Full Text] [Related]
84. Normal and abnormal regulation of 1,25-(OH)2D synthesis. Breslau NA Am J Med Sci; 1988 Dec; 296(6):417-25. PubMed ID: 3063116 [TBL] [Abstract][Full Text] [Related]
85. Effect of 24,25(OH)2D3 on PTH levels and bone histology in dogs with chronic uremia. Olgaard K; Finco D; Schwartz J; Arbelaez M; Teitelbaum S; Avioli L; Klahr S; Slatopolsky E Kidney Int; 1984 Dec; 26(6):791-7. PubMed ID: 6335904 [TBL] [Abstract][Full Text] [Related]
86. Regulation of vitamin D metabolism in normal human pregnancy. Reddy GS; Norman AW; Willis DM; Goltzman D; Guyda H; Solomon S; Philips DR; Bishop JE; Mayer E J Clin Endocrinol Metab; 1983 Feb; 56(2):363-70. PubMed ID: 6600459 [TBL] [Abstract][Full Text] [Related]
87. The Impact of Chronic Kidney Disease on Nutritional Status and Its Possible Relation with Oral Diseases. Costacurta M; Basilicata M; Marrone G; Di Lauro M; Campolattano V; Bollero P; Docimo R; Di Daniele N; Noce A Nutrients; 2022 May; 14(10):. PubMed ID: 35631140 [TBL] [Abstract][Full Text] [Related]
88. Vitamin D in Chronic Kidney Disease and Dialysis Patients. Jean G; Souberbielle JC; Chazot C Nutrients; 2017 Mar; 9(4):. PubMed ID: 28346348 [TBL] [Abstract][Full Text] [Related]
89. Estimated GFR and circulating 24,25-dihydroxyvitamin D3 concentration: a participant-level analysis of 5 cohort studies and clinical trials. de Boer IH; Sachs MC; Chonchol M; Himmelfarb J; Hoofnagle AN; Ix JH; Kremsdorf RA; Lin YS; Mehrotra R; Robinson-Cohen C; Siscovick DS; Steffes MW; Thummel KE; Tracy RP; Wang Z; Kestenbaum B Am J Kidney Dis; 2014 Aug; 64(2):187-97. PubMed ID: 24703961 [TBL] [Abstract][Full Text] [Related]
90. Calcitriol, calcidiol, parathyroid hormone, and fibroblast growth factor-23 interactions in chronic kidney disease. de Brito Galvao JF; Nagode LA; Schenck PA; Chew DJ J Vet Emerg Crit Care (San Antonio); 2013; 23(2):134-62. PubMed ID: 23566108 [TBL] [Abstract][Full Text] [Related]
91. Impaired vitamin D metabolism in CKD. Bosworth C; de Boer IH Semin Nephrol; 2013 Mar; 33(2):158-68. PubMed ID: 23465502 [TBL] [Abstract][Full Text] [Related]
92. Hyperphosphataemia in renal failure: causes, consequences and current management. Albaaj F; Hutchison A Drugs; 2003; 63(6):577-96. PubMed ID: 12656655 [TBL] [Abstract][Full Text] [Related]
93. Vitamin D and its analogs in chronic renal failure. Slatopolsky E; Brown AJ Osteoporos Int; 1997; 7 Suppl 3():S202-8. PubMed ID: 9536333 [No Abstract] [Full Text] [Related]
94. Nephrology, dialysis and transplantation. Farrington K; Sweny P Postgrad Med J; 1990 Jul; 66(777):502-25. PubMed ID: 2217007 [No Abstract] [Full Text] [Related]
95. Vitamin D kinetics in vivo: effect of 1,25-dihydroxyvitamin D administration. Halloran BP; Castro ME Am J Physiol; 1989 May; 256(5 Pt 1):E686-91. PubMed ID: 2785765 [TBL] [Abstract][Full Text] [Related]
96. Extra-renal production of calcitriol in chronic renal failure. Dusso A; Lopez-Hilker S; Rapp N; Slatopolsky E Kidney Int; 1988 Sep; 34(3):368-75. PubMed ID: 3172645 [TBL] [Abstract][Full Text] [Related]
97. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
98. On the mechanisms for the selective action of vitamin D analogs. Dusso AS; Negrea L; Gunawardhana S; Lopez-Hilker S; Finch J; Mori T; Nishii Y; Slatopolsky E; Brown AJ Endocrinology; 1991 Apr; 128(4):1687-92. PubMed ID: 2004595 [TBL] [Abstract][Full Text] [Related]
99. Metabolic clearance rate and production rate of calcitriol in uremia. Dusso A; Lopez-Hilker S; Lewis-Finch J; Grooms P; Brown A; Martin K; Slatopolsky E Kidney Int; 1989 Mar; 35(3):860-4. PubMed ID: 2709678 [TBL] [Abstract][Full Text] [Related]